ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Supernus Pharmaceuticals, INC.

Official 2024 U.S. DOL Form 5500 summary for Supernus Pharmaceuticals, INC. (Supernus Pharmaceuticals, INC. 401(k) Profit Sharing Plan · EIN 20-2590184 · PN 001): $117.01M net assets, 675 active participants, and $11.16 per $10,000 (11.16 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorSupernus Pharmaceuticals, INC.
Filing IdentifierSupernus Pharmaceuticals, INC. 401(k) Profit Sharing Plan · EIN 20-2590184 · PN 001
Plan Category & State401(k) Defined Contribution (MD)
Asset-Size Peer Cohort$100M-$500M
Plan Net Assets (2024)$117.01M
Active Participants675
Direct Admin Fee Rate$11.16 per $10,000 (11.16 bps)
Cohort Peer Median$9.75 per $10,000 (9.75 bps)
Primary Recordkeeper / ProviderFidelity Investments
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI